CD44 and cancer: Furthermore, the SPP1/CD44-mediated crosstalk between SPP1+ macrophages and cancer cells in the SPP1+ macrophage-enriched region formed a specific niche to accelerate the malignant progression of GC, which means that the architecture of intratumor heterogeneity may evolve with tumor progression.